ACR 2022 Tweet by Md Yuzaiful Md Yusof

Tweet
Md Yuzaiful Md Yusof @Yuz6Yusof Nov 12, 2022
View on
#ACR22 Abstr#2081 What is the nature of breakthrough #COVID infection in #lupus patients in Omicron era? A cohort study in New York showed those receiving booster vac were less likely to develop infection vs receiving 2 vaccine doses. Only 2 hospitalised, no deaths @RheumNow
Image from Md Yuzaiful Md Yusof’s tweet

Related Content

Article Anti-Rheumatic Rx

COVID Virus Persistence with DMARD Use

MedPage Today Apr 30, 2026
Drugs commonly used to treat systemic autoimmune rheumatic diseases (SARDs) may keep the SARS-CoV-2 circulating after COVID-19 infection in patients with these conditions, with researchers documenting substantially increased viral antigen persistence compared with other post-COVID patients.
Article Lupus

Petri SLE Pearls: An Update

Kathryn H. Dao, M.D. Oct 1, 2026
At the CCR West 2026 conference in Huntington Beach, California, Dr. Michelle Petri updated her Petri Pearls. Some are derived from new data, while others are from her extensive experience caring for patients with systemic lupus erythematosus (SLE). As always, her observations and wisdom have…
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

Topics

×